Impax Asset Management Group »

Regeneron Pharmaceuticals shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-03-31 $779k 1.2k 634.23
2024-12-31 $1.9M 2.6k 712.33
2024-09-30 $5.9M 5.6k 1051.24
2024-06-30 $5.7M 5.4k 1051.03

More positions owned by Impax Asset Management Group

Linde Common Stock (LIN)
Microsoft Corp Common Stock (MSFT)
Xylem Common Stock (XYL)
NVIDIA Corp Common Stock (NVDA)
Veralto Corp Common Stock (VLTO)
Hubbell Common Stock (HUBB)
Pentair Common Stock (PNR)
Aptiv Common Stock (APTV)
Agilent Technologies Common Stock (A)
A O Smith Corp Common Stock (AOS)
Advanced Drainage Systems Common Stock (WMS)
IDEX Corp Common Stock (IEX)
RenaissanceRe Holdings Common Stock (RNR)
Synopsys Common Stock (SNPS)
Marvell Technology Common Stock (MRVL)

View all positions for Impax Asset Management Group

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals